These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

175 related items for PubMed ID: 9865255

  • 21. Conversion to tacrolimus for acute corticosteroid- and antibody-resistant rejection following kidney transplantation.
    Kliem V, Radermacher J, Hiss M, Pethig M, Burg M, Brunkhorst R.
    Transplant Proc; 1999 Nov; 31(7A):37S-40S. PubMed ID: 10576041
    [No Abstract] [Full Text] [Related]

  • 22. Lower incidence of liver graft rejection in patients on diltiazem plus cyclosporine therapy.
    Mies S, Massarollo PC, Figueira ER, Leitão RM, Raia S.
    Transplant Proc; 1998 Jun; 30(4):1437-8. PubMed ID: 9636582
    [No Abstract] [Full Text] [Related]

  • 23. Prospective study of a tacrolimus-based quadruple immunosuppressive regimen: evaluation of safety and efficacy.
    Lladó L, Figueras J, Ramos E, Baliellas C, Torras J, Rafecas A, Fabregat J, Lama C, Ibañez L, Jaurrieta E.
    Transplant Proc; 2002 Aug; 34(5):1526-8. PubMed ID: 12176468
    [No Abstract] [Full Text] [Related]

  • 24. Use of FK506 as primary or rescue therapy after liver transplantation in Hong Kong.
    Lo CM, Fan ST, Liu CL, Chan KL, Ng IO, Lai CL, Lau GK, Fung SK, Wong J.
    Transplant Proc; 1998 Nov; 30(7):3587-8. PubMed ID: 9838571
    [No Abstract] [Full Text] [Related]

  • 25. Steroid withdrawal 3 months after liver transplantation--does FK 506 confer any advantage over cyclosporin?
    Dmitrewski J, Ayres S, Gunson BK, Buist LJ, Buckels JA, McMaster P, Mayer AD.
    Transpl Int; 1994 Nov; 7 Suppl 1():S85-7. PubMed ID: 11271342
    [Abstract] [Full Text] [Related]

  • 26. Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients.
    Ontañón J, Muro M, García-Alonso AM, Minguela A, Torío A, Bermejo J, Pons JA, Campos M, Alvarez-López MR.
    Transplantation; 1998 Apr 27; 65(8):1047-53. PubMed ID: 9583864
    [Abstract] [Full Text] [Related]

  • 27. Long-term follow-up in hepatitis C patients with respect to immunosuppression.
    Mueller AR, Platz KP, Berg T, Fukomoto T, Guckelberger O, Neuhaus R, Bechstein WO, Hopf U, Lobeck H, Neuhaus P.
    Transplant Proc; 1996 Dec 27; 28(6):3241-2. PubMed ID: 8962255
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Indications for mycophenolate mofetil therapy in hepatitis C-patients undergoing liver transplantation.
    Platz KP, Mueller AR, Willimski C, Mansoorian B, Berg T, Neuhaus R, Hopf U, Lobeck H, Neuhaus P.
    Transplant Proc; 1998 Jun 27; 30(4):1468-9. PubMed ID: 9636596
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. One hundred children treated with tacrolimus after primary orthotopic liver transplantation.
    McDiarmid S, Goss J, Seu P, Shackleton C, Vargas J, Ament M, Busuttil R.
    Transplant Proc; 1998 Jun 27; 30(4):1397-8. PubMed ID: 9636564
    [No Abstract] [Full Text] [Related]

  • 34. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P, Bechstein WO, Blumhardt G, Lange D, Schattenfroh N, Neuhaus P.
    Transplant Proc; 1993 Aug 27; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract] [Full Text] [Related]

  • 35. Tacrolimus therapy for refractory acute renal allograft rejection: a 4-year experience with an aggressive approach.
    Turner CD, Bruce DS, Cronin DC, Loss GE, Grewal H, Siegel C, Millis JM, Newell KA, Davis B, Todo T, Thistlethwaite JR, Woodle ES.
    Transplant Proc; 1998 Jun 27; 30(4):1234-5. PubMed ID: 9636501
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Acute rejection and the therapeutic choice of drug.
    Ichikawa Y, Nojima M, Kyo M, Yazawa K, Hanafusa T, Ebisui C, Tsubakihara Y, Fukunishi T, Nagano S.
    Transplant Proc; 2000 Nov 27; 32(7):1759-60. PubMed ID: 11119923
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.